抗体和补充是血栓形成的关键驱动因素
Konstantin Stark1, Badr Kilani1, Sven Stockhausen1
1Medizinische Klinik und Poliklinik I, University Hospital, LMU Munich, Munich, Germany; German Center for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany; Walter-Brendel Center of Experimental Medicine, Faculty of Medicine, LMU Munich, Munich, Germany.
Immunity
|September 3, 2024
概括
抗体,特别是免疫球蛋白M (IgM) 和免疫球蛋白G (IgG),通过激活内皮细胞和血小板来驱动血栓形成. 这种抗体驱动的血栓形成可以向预防凝块,而不会影响正常的血静.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 血管生物学 血管生物学
背景情况:
- 静脉血栓栓塞 (VTE) 是致病率和死亡率的重要原因,其发病率越来越高.
- 抗体升高和血栓事件之间存在临床关联,但潜在的机制尚不清楚.
研究的目的:
- 阐明抗体在血栓形成中的作用.
- 为了确定抗体介导血栓形成的新型治疗点.
主要方法:
- 在血液流量减少的情况下,研究了与FcμR和pIgR的抗体相互作用.
- 评估了内皮激活,血小板招募和IgG沉积.
- 检查了补充激活路径.
- 人类静脉静止和COVID-19模型中的验证结果.
主要成果:
- 减少的血流促进IgM与FcμR和pIgR的结合,启动内皮激活和血小板招募.
- 活化血小板促进抗原和FcγR独立的IgG沉积,导致补充激活.
- 这种由抗体驱动的前栓塞级联在人体静脉静止和COVID-19中观察到.
- 向补充剂有效地预防了抗体驱动的血栓形成.
结论:
- 抗体是血栓形成的中央调节者,与它们在免疫中的作用不同.
- 这种机制为血栓形成治疗提供了一个目标,可以避免血液静止.
- 这些发现对基于抗体的疗法和血栓形成管理有影响.
相关概念视频
Complement System
2.3K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.3K
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Antimicrobial Proteins
951
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
951
Humoral Immune Responses
72.3K
Overview
72.3K
Clot Retraction and Fibrinolysis
4.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.9K


